Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof

Details for Australian Patent Application No. 2004207075 (hide)

International Classifications

Event Publications

25 August 2005 PCT application entered the National Phase

PCT publication WO2004/067561 Priority application(s): WO2004/067561

4 March 2010 Amendment Made

The nature of the amendment is: Amend the invention title to read Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof 2004213989 Qualcomm Incorporated The nature of the amendment is as shown in the statement(s) filed 03 Sep 2009

8 April 2010 Corrigenda

Amendments - Amendments Made Under the name Abbott GmbH & Co. KG, Application No. 2004207075, under INID(54), correct the invention title to Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use thereof Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2004209418 Landmark Graphics Corporation, a division of Halliburton

20 January 2011 Application Accepted

Published as AU-B-2004207075

3 February 2011 Application for Amendment

The nature of the amendment is: Amend invention title to read Amyloid-beta(1-42), derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof. Address for service in Australia - Watermark Patent and Trade Marks Attorneys Level 2 302 Burwood Road Hawthorn VIC 3122

26 May 2011 Amendment Made

The nature of the amendment is: Amend the invention title to read Amyloid-beta(1-42), derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof 2004287879 Novartis Vaccines and Diagnostics, Inc. The nature of the amendment is as shown in the statement(s) filed 12 Jan 2011

26 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.